Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy

Abstract

loading...

About

This paper, published in 1950, received 381 indexed citations. Written by Isaline Rowe, Marco Chiaravalli, Valeria Mannella, Giacomo Quilici, Monika Pema, Xuewen Song, Hangxue Xu, Silvia Mari, Feng Qian and York Pei covering the research area of Genetics, Pathology and Forensic Medicine and Molecular Biology. It is primarily cited by scholars working on Genetics (272 citations), Molecular Biology (240 citations) and Pathology and Forensic Medicine (117 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm.3092 →

Countries where authors are citing Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy

Since Specialization
Citations

This map shows the geographic impact of Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy more than expected).

Fields of papers citing Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm.3092.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026